Xyphos, a privately held biotechnology company, is focused on the creation and development of immuno-oncology therapeutics designed to harness the power of a patient’s immune system to cure cancer. Xyphos’ novel and proprietary ACCEL (Advanced Cellular Control through Engineered Ligands) technology platform allows new and potentially better ways to mobilize and control engineered immune cells to find and destroy cancer cells. Xyphos’ first convertibleCAR-T cell product candidate is in preclinical development and is scheduled to be tested in a first-in-human clinical study in early 2020. Validating its approach, Xyphos entered in a collaboration with the Parker Institute for Cancer Immunotherapy to apply its ACCEL technology to novel cancer treatments.
View Top Employees from Xyphos Biosciences| Website | http://www.xyphosinc.com |
| Revenue | $5 million |
| Employees | 6 (3 on RocketReach) |
| Founded | 2017 |
| Address | 100 Kimball Way, South San Francisco, California 94080, US |
| Phone | (650) 243-2951 |
| Fax | (650) 362-6585 |
| Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
| Category | Biotechnology, Business Services, Other Pharmaceuticals and Biotechnology |
| SIC | 87, 873 |
| NAICS | 54171, 54, 541714, 541, 5417 |
Looking for a particular Xyphos Biosciences employee's phone or email?
Xyphos Biosciences Questions
The Xyphos Biosciences annual revenue was $5 million in 2023.
Noboru Yamaji is the President of Xyphos Biosciences.
3 people are employed at Xyphos Biosciences.
Xyphos Biosciences is based in South San Francisco, California.
The NAICS codes for Xyphos Biosciences are [54171, 54, 541714, 541, 5417].
The SIC codes for Xyphos Biosciences are [87, 873].
Top Xyphos Biosciences Employees
-
-
45+
Related Companies
